Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05917561
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2023-05-31
Brief Title:
Efficacy and Tolerance of the Association of ANIFROLUMAB 300mg IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Sponsor:
University Hospital Bordeaux
Organization:
University Hospital Bordeaux
Organization Data
Organization:
University Hospital Bordeaux
Class:
OTHER
Study ID:
CHUBX 202203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Bordeaux
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |